pharmaceutical lawyers

Tag Archive

Warned: Non-Medical COVID-19 Treatment Producers

Warned: Non-Medical COVID-19 Treatment Producers

| Pharmaceutical Litigation
The Federal Trade Commission and Food and Drug Administration recently told seven companies to either stop selling certain products or revise their claims. In a mass letter to Vital Silver, GuruNanda, LLC, Vivify Holistic Clinic, Herbal Amy LLC, Quinessence Aromatherapy Ltd., Xephyr, LLC doing business as N-Ergetics, and The Jim Baker Show, regulators said these…Read the article
Medtronic Recalls Faulty Insulin Pumps

Medtronic Recalls Faulty Insulin Pumps

| Pharmaceutical Litigation
After evidence of a possible life-threatening defect came to light, Medtronic, the medical device giant issued an immediate recall for its MiniMed Insulin Pumps. The recall covers over 300,000 devices which were sold in the United States beginning in June 2017. Medtronic touted these pumps as safe to use for people as young as seven…Read the article
How Safe Are Dietary Supplements?

How Safe Are Dietary Supplements?

| Pharmaceutical Litigation
Will dietary supplement keep me safe from coronavirus? Physical health often wards off viral infections. But tread cautiously. In the United States, dietary supplements exist in a legal grey area. So, they are not always safe. Dietary health is essential for overall physical health. Supplements do not replace a healthy diet, but in many cases,…Read the article
Bladder Medication Can Cause Blindness

Bladder Medication Can Cause Blindness

| Pharmaceutical Litigation
Orphan drug affects eyesight Having been widely prescribed for decades, the Elmiron bladder medication has recently been found to be toxic to the retina (damage). An article published by the American Academy of Ophthalmology in 2018 described six patients experiencing pigmentary maculopathy after chronic exposure to Elmiron (pentosan polysulfate sodium) for interstitial cystitis. The following…Read the article
Government Recalls Diabetes Drug

Government Recalls Diabetes Drug

| Pharmaceutical Litigation
After government inspectors found traces of a cancer-causing chemical in Metformin, the Food and Drug Administration ordered a recall of one of the most commonly-prescribed diabetes drugs in America. FDA officials discovered a dangerous chemical, N-Nitrosodimethylamine, in five different Metformin versions. About 34 million Americans have Type 2 Diabetes, and many of them take some…Read the article
Headaches Ahead for Zantac Labs

Headaches Ahead for Zantac Labs

| Pharmaceutical Litigation
Heartburn Heaven As recently as August 2019, the ranitidine market was tipped to top a gut-gripping US$ 485.4 million by 2026. Introduced in 1981, this popular antacid – better known as Zantac – was the world’s top-selling prescription drug just six years later. In fact, sweetening the world’s sour stomachs proved a bottomless well of…Read the article
FDA Demands Zantac Recall

FDA Demands Zantac Recall

| Pharmaceutical Litigation
Recent evidence links the popular heartburn medication to an increased cancer risk, thus FDA demands Zantac recall. The agency wants all ranitidine off store shelves effective immediately. Currently, the Food and Drug Administration is sending letters to Sanofi and other ranitidine manufactures asking them to stop making and shipping product. Additionally, the FDA advises consumers…Read the article
Zantac Injury Attorneys

Zantac Injury Attorneys

| Pharmaceutical Litigation
Over-the-counter Zantac (Ranitidine) is already one of the largest-selling antacids in the United States. Annual revenue exceeds $125 million. That market share was expected to triple by 2026. Then, the Food and Drug Administration found a dangerously-high level of a cancer-causing compound in Zantac. The watchdog then ordered Sanofi to stop selling the drug in…Read the article
Possible FDA Crackdown Against CBD Products

Possible FDA Crackdown Against CBD Products

| Pharmaceutical Litigation
The Food and Drug Administration told over a dozen companies to stop selling cannabidiol-infused food products and stop making inflated health claims about their products. CBD is a non-psychoactive marijuana ingredient which has medicinal properties. Yet the FDA has only approved one CBD product. Epidiolex treats some rare forms of childhood epilepsy. Other CBD products,…Read the article
Major Win for Dangerous Drug Victims

Major Win for Dangerous Drug Victims

| Pharmaceutical Litigation
A Philadelphia jury ordered Johnson & Johnson subsidiary Janssen Pharmaceuticals to pay $8 billion in a drug-induced gynecomastia matter.  26-year-old Nicholas Murray developed abnormally large breasts in 2003. He had been taking Risperdal, an antipsychotic drug, to control his autism spectrum disorder symptoms. In a statement, J&J said it would appeal the “grossly disproportionate” award.…Read the article